Monopar Therapeutics (MNPR) Upgraded by Zacks Investment Research to Buy

Monopar Therapeutics} stock has undergone multiple analysts rating changes in the recent past.  Monopar Therapeutics Upgraded by Zacks Investment Research on 10/13/2021. In a note to investors, the firm issued a new rating of Buy. The analysts previously had rating of Hold.

View More Monopar Therapeutics (MNPR) Upgraded by Zacks Investment Research to Buy

Does Earnings Surprise History Hold Any Clue for NASDAQ:MNPR, NASDAQ:CETX, NASDAQ:FMTX, NASDAQ:DUO

Quarterly, annual earnings. See the latest EPS estimates vs Actual and surprise it caused. Stock Market Daily has their analysis…

View More Does Earnings Surprise History Hold Any Clue for NASDAQ:MNPR, NASDAQ:CETX, NASDAQ:FMTX, NASDAQ:DUO

Does Earnings Surprise History Hold Any Clue for NASDAQ:ORBC, NASDAQ:HBIO, NASDAQ:MNPR, NASDAQ:LSEA

Quarterly, annual earnings. See the latest EPS estimates vs Actual and surprise it caused. Stock Market Daily has their analysis…

View More Does Earnings Surprise History Hold Any Clue for NASDAQ:ORBC, NASDAQ:HBIO, NASDAQ:MNPR, NASDAQ:LSEA

Wall street estimates Earnings report Monopar Therapeutics (NASDAQ:MNPR)

Earnings results for Monopar Therapeutics , Analyst Opinion on Monopar Therapeutics , Earnings and Valuation of (NASDAQ:MNPR), Stock market Insights & financial analysis, Best stock to invest, Investment Idea,

View More Wall street estimates Earnings report Monopar Therapeutics (NASDAQ:MNPR)

Does Earnings Surprise History Hold Any Clue for Monopar Therapeutics (NASDAQ:MNPR)

Earnings results for Monopar Therapeutics , Analyst Opinion on Monopar Therapeutics , Earnings and Valuation of (NASDAQ:MNPR), Stock market Insights & financial analysis, Best stock to invest, Investment Idea,

View More Does Earnings Surprise History Hold Any Clue for Monopar Therapeutics (NASDAQ:MNPR)

Earnings Report: Here’s what to expect from Monopar Therapeutics (NASDAQ:MNPR)

Earnings results for Monopar Therapeutics , Analyst Opinion on Monopar Therapeutics , Earnings and Valuation of (NASDAQ:MNPR), Stock market Insights & financial analysis, Best stock to invest, Investment Idea,

View More Earnings Report: Here’s what to expect from Monopar Therapeutics (NASDAQ:MNPR)